Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Myovant Sciences Q2 EPS $(0.47) Beats $(0.48) Estimate, Sales $104.82M Miss $110.45M Estimate

Author: Benzinga Newsdesk | October 26, 2022 08:37am
Myovant Sciences (NYSE:MYOV) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 37.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $104.82 million which missed the analyst consensus estimate of $110.45 million by 5.09 percent.

Posted In: MYOV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist